R
Power Law company profile
RayzeBio
Biotech & Life Sciences · San Diego, United States · Founded 2020 · IPO 2023 Unicorn
Valuation
$3.74B
Market cap · 2026
Global footprint
Where RayzeBio has talent and traffic
AI talent share
0.8%
of workforce is AI talent
(2 of 249 staff)
(2 of 249 staff)
Core AI10.4%
Other AI10.4%
Non-AI workforce24799.2%
Web traffic by country
6K
monthly visits
across markets
across markets
🇺🇸 United States73.3%
🇮🇳 India26.7%
Patent intelligence
$380k patent portfolio · 13 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$380k
0.01% of market cap · 173.1× smaller than top peer Ascentage Pharma ($66M)
13 active patent families
Where RayzeBio innovates
CarcinosisRadioactive drugPharmaceutical drugTargeting ligandsMetal Chelator
Below peer median on Legal, Market
Quality vs same-sector peers
RayzeBio on the five Patsnap quality dimensions
RayzeBio in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where RayzeBio concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across RayzeBio and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee RayzeBio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.